On The Web![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif){kind=icon}
Site SearchMorrisville, N.C. — Biopharmaceutical development firm Trimeris faces a lawsuit over the HIV drug it developed called Fuzeon.
In a Securities and Exchange Commission filing on Tuesday, Trimeris (Nasdaq: TRMS) said it had been sued by Novartis. Roche, Trimeris’ partner in developing and selling Fuzeon, is also included in the suit.
Novartis is alleging patent infringement. According to Trimeris, Novartis received the patent at the center of the case, about one month ago.
Fuzeon was approved for sale in 2003.
Trimeris Faces Lawsuit over HIV Drug
Copyright 2008 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- Argos Therapeutics wraps up remainder of $35.2M in financing
Updated Nov. 21 3:06 p.m. - Internet Summit - Lots of highs, a few lows
Updated Nov. 21 1:19 p.m. - N.C. adds jobs but unemployment rate reaches 7%
Updated Nov. 21 10:16 p.m. - Duke cardiologist could be next head of FDA
Nov. 21, 2008 - Future shock? A more dangerous world looms, warns new report
Updated Nov. 21 8:51 a.m.
- Argos Therapeutics wraps up remainder of $35.2M in financing
-
- What do entrepreneurs do now?
Nov. 20, 2008 - Internet Summit consensus: SaaS is hot!
Nov. 20, 2008 - Atlanta chip startup VT Silicon lands $5.5M in financing
Nov. 20, 2008 - Quit building mansions and focus on execution, Lulu’s Bob Young says
Nov. 20, 2008 - Interact911 closes on $28M in new financing
Nov. 20, 2008
- What do entrepreneurs do now?
More from wrallocaltechwire.com
Market Watch
